Viewing Study NCT01823068


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-01-05 @ 5:38 PM
Study NCT ID: NCT01823068
Status: COMPLETED
Last Update Posted: 2020-12-07
First Post: 2013-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vandetanib in Advanced NSCLC With RET Rearrangement
Sponsor: Samsung Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vandetanib View
None Lung cancer View
None RET fusion View